Hosted on MSN8mon
Moderna rival CSPC cleared to study RSV shot in ChinaShijiazhuang-based CSPC (OTCPK:CHJTF) said that SYS6016 has already undergone preclinical trials, neutralizing both RSV-A and RSV-B strains of the virus with a favorable safety profile.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback